[Federal Register Volume 85, Number 10 (Wednesday, January 15, 2020)]
[Notices]
[Pages 2429-2430]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-00505]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Docket No. HHS-OS-2019-0015]


Solicitation for Public Comments on Questions From the National 
Clinical Care Commission

AGENCY: Office of Disease Prevention and Health Promotion, Office of 
the Assistant Secretary for Health, Office of the Secretary, Department 
of Health and Human Services.

ACTION: Request for public comment.

-----------------------------------------------------------------------

SUMMARY: The National Clinical Care Commission (the Commission) 
solicits public comments on a set of questions concerning the context, 
policies, effectiveness, promising practices, and limitations and gaps 
related to prevention and treatment of diabetes and its complications. 
The Commission is charged to evaluate and make recommendations to the 
Secretary of Health and Human Services (HHS) and Congress regarding 
improvements to the coordination and leveraging of federal programs 
related to awareness and clinical care for diabetes and its 
complications. The set of questions is available in the SUPPLEMENTARY 
INFORMATION section, below.

DATES: Electronic or written/paper comments will be accepted through 
midnight Eastern Standard Time (EST) February 3, 2020.

ADDRESSES: Public comments can be submitted in the following ways:
     Electronic submissions can be filed on the online docket 
at http://www.regulations.gov by following the ``Instructions for 
Public Comments'' section, below. Evidence and information supporting 
your comments can be submitted as attachments. Comments submitted 
electronically, including supporting attachments, will be posted to the 
docket unchanged. Please provide your contact information or 
organization name on the web-based form for potential follow up by the 
Commission.
     If you prefer to comment on paper, mail your comments to 
the following address: Public Commentary, National Clinical Care 
Commission, 1101 Wootton Parkway, Suite 420, Rockville, MD 20852. For 
mailed submissions, the Office of Disease Prevention and Health 
Promotion will post your comments, as well as any attachments, to 
http://www.regulations.gov.
    Instructions for Public Comments: All electronic submissions must 
be submitted in the Docket ID HHS-OS-2019-0015 for ``Solicitation for 
Public Comments on Questions from the National Clinical Care 
Commission.'' For access to the docket to provide and/or read all 
comments received, go to https://www.regulations.gov and insert the 
docket ID HHS-OS-2019-0015 into the search box and follow the prompts.
    Comments are encouraged from the public and will be accepted 
through February 3, 2020. The https://www.regulations.gov electronic 
filing system will accept electronic comments until midnight Eastern 
Standard Time at the end of February 3, 2020. Comments received by 
mail/courier will be considered if they are postmarked or the delivery 
service acceptance receipt date is on or before that date. Written 
comments via mail will be uploaded into https://www.regulations.gov and 
are under the same limitations as for those directly submitted 
electronically into https://www.regulations.gov: 5,000-character limit 
for text box, and maximum number (10) of attached files and maximum 
size (10 MB) of each attached file.

FOR FURTHER INFORMATION CONTACT: Linda Harris, Designated Federal 
Officer, National Clinical Care Commission, U.S. Department of Health 
and Human Services, Office of the Assistant Secretary for Health, 
Office of Disease Prevention and Health Promotion, 1101 Wootton 
Parkway, Suite 420, Rockville, MD 20852. Email: [email protected].

SUPPLEMENTARY INFORMATION: The National Clinical Care Commission Act 
(Pub. L. 115-80) requires the HHS Secretary to establish the National 
Clinical Care Commission. The Commission consists of representatives of 
specific federal agencies and non-federal individuals and entities who 
represent diverse disciplines and views. The Commission will evaluate 
and make recommendations to the HHS Secretary and Congress regarding 
improvements to the coordination and leveraging of federal programs 
related to awareness and clinical care for diabetes and its 
complications.
    The Commission invites members of the public to comment on any 
issues or concerns they believe are relevant or appropriate to the 
Commission's evaluation of federal programs. Specifically, the 
Commission requests public comment on the following questions:
    1. Context: What social, economic, and/or environmental factors 
have the greatest impact on health care in general--and also on 
prevention (Type 2) and/or management of diabetes (both Type 1 and Type 
2)? What can be done by the federal government to address those social/
economic/environmental factors?
    2. Policies: What policies should the federal government implement 
to improve diabetes prevention and/or management? What is the evidence 
to support those?

[[Page 2430]]

    3. Effectiveness: What specific recommendations do you have for 
federal agencies to be more effective and/or to collaborate better to 
prevent and/or help manage diabetes? What is the basis for your 
specific recommendations?
    4. Promising Practices: What are the best and/or most promising 
practices to prevent diabetes and/or to improve diabetes outcomes? What 
is the evidence to support them?
    5. Limitations and gaps: What are the greatest limitations or gaps 
in federal programs to prevent diabetes and/or to improve diabetes 
outcomes? What could the Federal government do to close the gaps? Are 
there specific research needs? Are there specific research needs or 
programs that would benefit from new or increased collaboration across 
federal agencies?

Don Wright,
Deputy Assistant Secretary for Health, Disease Prevention and Health 
Promotion.
[FR Doc. 2020-00505 Filed 1-14-20; 8:45 am]
BILLING CODE 4150-32-P